Cargando…
Extensively drug-resistant tuberculosis in India: A review
BACKGROUND & OBJECTIVES: Extensively drug resistant tuberculosis (XDR-TB) has become a new threat for the control of TB in many countries including India. Its prevalence is not known in India as there is no nation-wide surveillance. However, there have been some reports from various hospitals in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516027/ https://www.ncbi.nlm.nih.gov/pubmed/23168700 |
_version_ | 1782252264408219648 |
---|---|
author | Michael, Joy Sarojini John, T. Jacob |
author_facet | Michael, Joy Sarojini John, T. Jacob |
author_sort | Michael, Joy Sarojini |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Extensively drug resistant tuberculosis (XDR-TB) has become a new threat for the control of TB in many countries including India. Its prevalence is not known in India as there is no nation-wide surveillance. However, there have been some reports from various hospitals in the country. METHODS: We have reviewed the studies/information available in the public domain and found data from 10 tertiary care centres in 9 cities in India. RESULTS: A total of 598 isolates of XDR Mycobacterium tuberculosis have been reported in the studies included. However, the reliability of microbiological methods used in these studies was not checked and thus the XDR-TB data remained invalidated in reference laboratories. INTERPRETATION & CONCLUSIONS: Systematic surveillance and containment interventions are urgently needed. |
format | Online Article Text |
id | pubmed-3516027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35160272012-12-11 Extensively drug-resistant tuberculosis in India: A review Michael, Joy Sarojini John, T. Jacob Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Extensively drug resistant tuberculosis (XDR-TB) has become a new threat for the control of TB in many countries including India. Its prevalence is not known in India as there is no nation-wide surveillance. However, there have been some reports from various hospitals in the country. METHODS: We have reviewed the studies/information available in the public domain and found data from 10 tertiary care centres in 9 cities in India. RESULTS: A total of 598 isolates of XDR Mycobacterium tuberculosis have been reported in the studies included. However, the reliability of microbiological methods used in these studies was not checked and thus the XDR-TB data remained invalidated in reference laboratories. INTERPRETATION & CONCLUSIONS: Systematic surveillance and containment interventions are urgently needed. Medknow Publications & Media Pvt Ltd 2012-10 /pmc/articles/PMC3516027/ /pubmed/23168700 Text en Copyright: © The Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Michael, Joy Sarojini John, T. Jacob Extensively drug-resistant tuberculosis in India: A review |
title | Extensively drug-resistant tuberculosis in India: A review |
title_full | Extensively drug-resistant tuberculosis in India: A review |
title_fullStr | Extensively drug-resistant tuberculosis in India: A review |
title_full_unstemmed | Extensively drug-resistant tuberculosis in India: A review |
title_short | Extensively drug-resistant tuberculosis in India: A review |
title_sort | extensively drug-resistant tuberculosis in india: a review |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516027/ https://www.ncbi.nlm.nih.gov/pubmed/23168700 |
work_keys_str_mv | AT michaeljoysarojini extensivelydrugresistanttuberculosisinindiaareview AT johntjacob extensivelydrugresistanttuberculosisinindiaareview |